| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ionis Pharmaceuticals, Inc. (IONS) has 21 insiders with recent SEC Form 4 filings, including 0 buys and 17 sells. IONS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 260.3K | $19.75M | - | |
| Dir | 164.0K | $12.45M | -8,000 | |
| VP | 100.3K | $7.61M | - | |
| VP | 83.3K | $6.32M | -60,846 | |
| CFO | 82.7K | $6.27M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 29, 2024 | Geary Richard S65 | EVP, Chief Development Officer | Sell | 651 | $49.40 | $32,158.73 | -0.4% | -28.1% | -14.6% | |
| Aug 5, 2024 | Geary Richard S65 | EVP, Chief Development Officer | Sell | 2,430 | $48.00 | $116,640.00 | -2.8% | -18.2% | -8.4% | |
| Jul 16, 2024 | Klein Joseph III60 | Director | Sale+OE | 12,000 | $50.00 | $600,000.00 | -100% | -22.5% | -14.2% | |
| Jul 16, 2024 | Diaz Allene M. | Director | Sale+OE | 1,637 | $49.49 | $81,019.40 | -4.8% | -22.5% | -14.2% | |
| Jun 17, 2024 | Berthelsen Spencer R | Director | Sale+OE | 16,000 | $40.29 | $644,640.00 | -9.8% | -0.1% | -11.3% | |
| May 3, 2024 | Klein Joseph III60 | Director | Sell | 6,000 | $42.71 | $256,276.57 | -29.5% | +22.3% | -21.9% | |
| Apr 16, 2024 | Baroldi Joseph52 | EVP, Chief Business Officer | Sale+OE | 4,006 | $41.60 | $166,640.79 | -16.9% | +14.5% | -31.8% | |
| Apr 16, 2024 | Birchler Brian52 | EVP, Corp And Development Ops | Sale+OE | 905 | $41.66 | $37,698.23 | -1.9% | +14.5% | -31.8% | |
| Feb 16, 2024 | Monia Brett P60 | Chief Executive Officer | Sell | 387 | $44.49 | $17,218.56 | -0.2% | -15.3% | -30.1% | |
| Feb 2, 2024 | O'Neil Patrick R.57 | EVP CLO &General Counsel | Sell | 1,961 | $49.67 | $97,410.32 | -3.9% | -13.4% | -35.9% |